logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
23/09/2025
JPMorgan Chase has announced the hiring of three senior bankers to strengthen its mid-market investment banking team and expand its presence in the transaction field. The bank stated that over the past year, the mid-market investment banking team has grown by 40% to ensure the ability to provide clients with tailored solutions and industry expertise.
Latest
1 m ago
JPMorgan: Raised Burberry's target price from 580 pence to 680 pence.
1 m ago
Tianhong Yu'ebao and other money market funds collectively reduce fees.
2 m ago
Traders said the Reserve Bank of India may be supporting the rupee by selling dollars through state-owned banks after the rupee fell to a historic low.
2 m ago
According to Every AI Newsflash, Huaxin Securities released a research report on September 23, giving Weis Medical (688580.SH) a buy rating. The reasons for the rating mainly include: 1) The company's expense ratio continued to improve in Q2 2025, leading to a substantial increase in profits; 2) The cornerstone business is stable, with high-speed growth in laser radiofrequency and electrophysiology products. (Daily Economic News)
2 m ago
Sangfor Technologies: The company is not currently participating in the supply chain of the Ascend 384 super node.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.